Results 241 to 250 of about 1,196,134 (401)
Qizhu Rougan Granules suppress liver fibrosis by inhibiting the expression of the P2Y14 receptor on hepatic stellate cells [PDF]
Tao Yue +7 more
openalex +1 more source
ROC analyses of APRI score, EOB‐MRI, and a combination of EOB‐MRI and APRI score for blue liver. ABSTRACT Aim Sinusoidal obstruction syndrome (SOS), also known as “blue liver (BL),” is a common hepatic injury following oxaliplatin‐based chemotherapy in patients with colorectal liver metastases (CRLM).
Tomonari Shimagaki +7 more
wiley +1 more source
Mechanistic insights into post-translational modifications in hepatic fibrosis: pathogenic roles and therapeutic potentials. [PDF]
Bai X, Liu Z, Li X, Sun R, Yu Z.
europepmc +1 more source
ABSTRACT Background Pancreatectomy for pancreatic ductal adenocarcinoma (PDAC) with arterial abutment is a complex, high‐risk surgery. We aimed to investigate the clinicopathological features, risk factors, and learning curve for local recurrence after pancreatectomy for PDAC with arterial abutment.
Jun Ishida +9 more
wiley +1 more source
MRI findings of confluent hepatic fibrosis caused by different etiologies. [PDF]
Yu D +6 more
europepmc +1 more source
MD Adriaan J. van der Meer +14 more
semanticscholar +1 more source
We retrospectively analyzed clinical data from patients who underwent hepatectomy for hepatocellular carcinoma (HCC) using LCA‐based grading system. These findings provide a new risk stratification framework for the design of precision surgery to treat patients with HCC.
Ling Liu +5 more
wiley +1 more source
Discovery of novel FABP1 inhibitors for the treatment of metabolic dysfunction-associated steatohepatitis and hepatic fibrosis. [PDF]
Zhou Z +7 more
europepmc +1 more source

